DISCOVER neva vs

A SPECIFIC DESIGN, A DECISIVE SOLUTION for post aSAH Vasospasm

NEVA VS FOR VASOSPASM: RECENT EVIDENCE

Click to watch the presentation highlighting NeVa VS as the game-changer in treating vasospasm after aneurysmal sub-arachnoid haemorrhage (aSAH) at the BRAIN CONFERENCE in London, December 2024.

“NeVa VS is a safe strategy to regain vessel diameter in severely narrowed proximal intracranial arteries”

– Dr. Ameer Hassan, Valley Baptist Neuroscience Institute, Harlingen, Texas

NEVA VS DILATE

THE FIRST POST-SAH VASOSPASM STUDY

NOW RECRUITING SITES!

CEREBRAL VASOSPASM
COMMON AND DEADLY

1 in 10000 People experience an aneurysm rupture every year. Up to 70% of these patients have to cope with cerebral vasospasm, the most common complication of aneurysmal Sub arachnoid haemorrhage (a-SAH) as well as the leading cause of delayed morbidity and mortality.

WITH NEW TREATMENT OPTIONS REVERSE VASOSPASM

Cerebral vasospasm is a life-threatening narrowing of brain vessels that usually occurs 7 to 10 days after an aSAH. The severe constriction limits blood flow to the affected area, causing delayed cerebral ischemia and poor neurological outcomes.

Today, with advances in technology and new treatment pathways, cerebral vasospasm could be reversible.

Case images courtesy of Dr Arthur Grigorian, MD, Wellstar North Fulton Medical Center. Roswell, Georgia

NEVA VS, SPECIFIC TO VASOSPASM TREATMENT

NeVa VS combines a smooth and continuous architecture and the deliverability of a stent retriever with an enhanced outward radial force to effectively dilate critically narrowed vessels.

EXPANSION OPTIMIZED

FLOW MAINTAINED

NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture. It combines a smooth and continuous architecture and the deliverability of a stent retriever with an enhanced outward radial force to effectively dilate critically narrowed vessels.

SPECIFIC

Designed For Vasospasm

Optimized Vessel Expansion

Distal Flow Maintained During Treatment

SUCCESSFUL

SAFE

No Vessel injuries or Ruptures

The VITAL Trial confirms NeVa VS to be a safe treatment for Cerebral Vasospasm. Click to find out more:

NEVA VS

IN ACTION

MODERATE-SEVERE BASILAR ARTERY VASOSPASM SUCCESSFULLY RESOLVED WITH NEVA VS

Dr Ryan M Hebert, Yale School of Medicine, New Haven, Connecticut

RIGHT MIDDLE CEREBRAL AND ANTERIOR CEREBRAL ARTERY VASOSPASM TREATED WITH NEVA VS

Dr Arthur Grigorian, Wellstar North Fulton Roswell, Georgia

approved for use
in the U.s.

NeVa VS is the first and only FDA HDE approved device for the adjunct treatment of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Approved by FDA under HDE 210004. Note: The effectiveness of this device for this use has not been demonstrated”

VASOSPASM Controlled

Would you like to know more?